Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain
- 1 April 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 58 (1) , 21-30
- https://doi.org/10.1016/0960-0760(96)00006-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Risk of endometrial cancer after tamoxifen treatment of breast cancerThe Lancet, 1994
- Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationThe Lancet, 1993
- Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens.Molecular and Cellular Biology, 1992
- Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.Journal of Clinical Oncology, 1992
- Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine TherapyJNCI Journal of the National Cancer Institute, 1991
- The Mechanism of ICI 164,384 Antiestrogenieity Involves Rapid Loss of Estrogen Receptor in Uterine TissueEndocrinology, 1991
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990
- Receptors, growth factors and steroid insensitivity of tumoursJournal of Endocrinology, 1990
- Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive stateJournal of Steroid Biochemistry, 1989
- The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimerCell, 1988